Abiopharma

🔍 Melgarejo Fernando Sabbi (Executive)

Company: PETROBRAS - PETROLEO BRASILEIRO SA (PBR)

Report Date: 2026-06-12

Detailed Transactions and Holdings:

• Sold 1,758 shares of Phantom Shares at $9.52 per share (Derivative)
  Date: 2026-06-12 | Code: D | equity_swap_involved: 0 | shares_owned_after: 21,070.59 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F2, F2

Footnotes:

• F1: Phantom shares are granted pursuant to the Petrobras Performance Award Program. The phantom shares are referenced to the PETR3 common share price and are settled in cash upon vesting. The deferred portion of the award vests in four equal annual instalments. Additional phantom shares are credited proportionally upon the payment of dividends or interest on equity by the company.
• F2: Weighted average of the last 20 trading sessions of Petrobras common shares, resulting in 48.40 BRL. The average is calculated as the sum of turnover divided by the sum of volume over these last 20 trading sessions. The price reported in column 2 is a convenience conversion of the 48.40 BRL per share into U.S. dollars based on the Central Bank of Brazil exchange rate of 5.0821 BRL per 1.00 USD on June 12th, 2026.